Skip to main content
. 2016 Dec 12;10(12):e0005219. doi: 10.1371/journal.pntd.0005219

Fig 2.

Fig 2

CD4+ T cell counts for HIV-infected participants (N = 12) across study visits (Panel A) and HIV VL across visits for participants with VL above the limit of detection at baseline (N = 4, Panel B). Individual subjects are represented by distinct lines in the graph.